Bionik Laboratories Corp. announced that Filling the role as Executive Vice President and Chief Financial Officer will be Dan Gonsalves, formerly Bionik's Corporate Controller. appointment is effective immediately.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 12 | |
-5.06% | 182B | |
+2.32% | 111B | |
-2.68% | 68.48B | |
+1.46% | 49.69B | |
+7.89% | 44.46B | |
+2.33% | 40.67B | |
+21.83% | 31.22B | |
+1.65% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- BNKL Stock
- News Bionik Laboratories Corp.
- Bionik Laboratories Corp. Appoints Dan Gonsalves as Chief Financial Officer